(Photo by kupicoo/Getty Images)
Blue Cross & Blue Shield of Rhode Island has partnered with Diagnostic Robotics to use artificial intelligence to identify and monitor members with certain chronic conditions.
Health risks targeted include congestive heart failure, obesity and behavioral health conditions.
Interventions include a mobile app to keep members engaged and connect them with the right network care provider in the most appropriate, cost-effective setting.
WHY THIS MATTERS
The partnership intends to effectively manage clinical care for Rhode Islanders and avoid unnecessary costs by focusing on targeted interventions, medical adherence and hospitalization prevention.
Diagnostic Robotics' systems integrate seamlessly into major touchpoints along the patient journey, providing high-value decision support while slashing administrative burdens, massively reducing the cost of care and improving patient experiences, BCBSRI said.
THE LARGER TREND
Diagnostic Robotics already has ties with academic institutions and the Rhode Island state government, including a research initiative with the Brown-Lifespan Center for Digital Innovation and a partnership to provide COVID-19 response technologies to the Rhode Island Department of Health.
The company's team includes leading artificial intelligence researchers from Israel and the United States. Diagnostic Robotics works extensively with healthcare systems in the United States and around the world, including the Mayo Clinic and numerous health systems in Israel.
ON THE RECORD
"This is just the beginning of a very exciting partnership with BCBSRI," said Yonatan Amir, CEO of Diagnostic Robotics. "BCBSRI recognizes the need for a new generation of capabilities to enable proactive and personalized care.
"We are proud to be part of their mission to equip Rhode Islanders with cutting-edge artificial intelligence and predictive analytics to keep members healthier while staying smart about spending."
"Behavioral health issues and chronic diseases can take an enormous toll on our members and their families, but timely interventions and evidence-based clinical guidance can help them connect with the right resources at the right time," said Dr. Matt Collins, executive vice president and chief medical officer.
"By applying the latest in machine learning, BCBSRI can better support population health."
Email the writer: email@example.com